Novel Therapy for Brain Tumors
The diagnosis and treatment of brain tumors is a rapidly evolving field. Traditional methods have changed regarding identification and use of genetic markers in various diseases. The World Health Organization, for example, recently revised its compendium on the classification of tumors of the central nervous system, taking into account genetic markers. Additional information provided from genetics has also altered the way various tumors are treated.
Surgical technology is also quickly evolving with the miniaturization of equipment which improves optics and lighting, thereby changing the way surgery is performed. This technology is being integrated with advanced imaging techniques to further change the extent and precision of resections that can be achieved. These advancements positively impact patient care and outcomes. Clinicians need to understand the impact that this new genetic information and technology has, and successfully apply it to their practice.
Visit events.houstonmethodist.org/novel-tumor-therapy for more information !
Houston Methodist Research Institute, 2nd Floor Auditorium
6670 Bertner Ave.
Houston Methodist CME